Tài liệu nghiên cứu về "ReviewMallotusrevised".
Trang 1Journal of Chemistry, Vol 45 (Special issue), P 111 - 121, 2007
REVIEW:
STUDY ON BENZOPYRANS AND OTHER ISOLATED
COMPOUNDS FROM MALLOTUS APELTA
Received 15 October 2007
NGUYEN HOAI NAM1, NGUYEN HAI DANG1, PHAN VAN KIEM1, LUU VAN CHINH1,
PHAN THI BINH2, LA DINH MOI3, AND CHAU VAN MINH1
1 Institute of Natural Products Chemistry, VAST
2 Institute of Chemistry, VAST
3 Institute of Ecology and Biological Reources, VAST
SUMMARY
During the last decades, dozens of compounds have been isolated from Mallotus apelta These compounds which are classified under the categories viz terpenoids, steroids, flavonoids, cumarino-lignoids, cembrane diterpenoids, and benzopyranoids They were known to exhibit interesting biological activities The phytochemical investigations revealed that malloapelta B which was the major component of M apelta, showed strong NF- B and NFAT transcription factor inhibitory and cytotoxic activities Numerous studies on the synthesis of some derivatives of malloapelta B were carried out This paper reviews the progress on the isolation, structure elucidation and biological activities of secondary metabolites from M apelta, especially, the new structures of benzopyrans Chemical modifications of malloapelta B and structure-activity relationship were also discussed
Keywords: Mallotus, mallotus apelta, benzopyran, malloapelta b.
I - INTRODUCTION
Ba bet (Mallotus) genus comprises about
140 species, distributed in regions from South to
South-East Asia, such as in Malaysian region
(about 75 species), in China (about 40 species)
and in Vietnam (about 40 species) [1] Mallotus
species have been used in traditional medicine
to treat various diseases For example Mallotus
apelta has been used to treat chronic hepatitis,
hepatalgia, enteritis, diarrhea, lymphopathy,
Mallotus repandus has been used to treat
influenza and fever, Mallotus barbatus has been
used in both Vietnamese and Chinese folk
medicine as antipyretic, diuretic, relieving pain
and curing cholera, Mallotus macrostachyus has
been used to treat wounds and pimple, Mallotus paniculatus has been used to treat traumatic
injuries and swelling [2, 3] To improve the
efficiency of using Mallotus species in
traditional medicine, it is neccesary to know their chemical components and pharmaceutical activity However, herbal medicine and its extracts contain hundreds of unknown components, which are often only present in a low amount Moreover, variability usually exists within the same herbal materials [4, 5] The chemical components may vary depending on harvest seasons, plant origins, drying processes and other factors [6] Therefore, investigation on the chemical components of the plant is important for pharmaceutical studies Since the
Trang 2last decades the scientists have been searching
for the chemical components, pharmaceutical
activity of Mallotus species and synthesizing
derivatives from isolated compounds from these
species The purpose of this review is to present
an overview of the studies on M apelta
including the isolation and structure elucidation
of bioactive compounds, chemical modifications
and synthetic processes.
II - PHYTOCHEMISTRY
The chemistry of M apelta has been widely
examined and the biological activity
investigations were carried out from all over of
the world The efforts have led to the isolation
of a number of physiologically active compounds viz terpenoids, steroids, flavonoids, cumarino-lignoids, cembrane diterpenoids, benzopyranoids We are actively working on the synthesis of some new derivatives of
malloapelta B, a major component of M apelta,
with an aim to find new derivatives having stronger bioactivity Various compounds
isolated from M apelta in different areas have
been classified under the categories terpenoids, steroids, flavonoids, cumarino-lignoids, cembrane diterpenoids, benzopyranoids and miscellaneous compounds as listed in figures
1-5
R
R HO
R1
R2
H O
O
R1
H3C R3
R2
1. CH3(CH)CH2OH H
3 CH2(C)CH2OH H
5. 3 - OH, 3 -H
6. 3 - OH, 3 -H
7. OH H CH3
8. COOH CH3 H
R2
HO
R
9. 3 -OH -(CH2)2CH(C2H5)CH(CH3)2
10 3 -OGla -(CH2)2CH(C2H5)CH(CH3)2
11 3 -OH -CH2=CH-CH(C2H5)CH(CH3)2
12 O
Figure 1: Terpenoids and steroids isolated from M apelta
Trang 3Terpenoids and steroids
The phytochemistry of M apelta has been
extensively studied since the early 1980s One
of the earlier phytochemical reports was
published in 1985, it described the isolation of
four triterpenes 3 , 29-dihydroxylupane (1),
erythrodiol-3-acetate (7), acetylursolic acid (8)
and -sitosterol (9) from the roots of this plant
[7] This plant also contains a variety of other
pentacyclic terpenoids Based on the spectral
and chemical evidence, their structures were
determined to be hennadiol (3), friedelin (4),
friedelanol (5), epifriedelanol (6), taraxerone (12), and epitaraxerol (13) [14, 16] and a new pentacyclic triterpene, named malloapelta A (2)
[15, 16, 19] From the methanol extract of M
apelta, daucosterol (10), stigmasterol (11), and
ergosterol (14) were isolated and purified using column chromatography over silica gel [19] Flavonoids
Two flavonoids quercitrin (15) and astilbin
(16) were identified from M apelta collected in
Vietnam [19]
OH OH
OH
HO
O O
OH HO
OH
O
15
OH OH
OH
HO
O O
OH HO
OH
O
16
Figure 2: Flavonoids isolated from M apelta
Cumarino-lignoids
A method for the isolation and purification
of three coumarino-lignoids aquillochin (17),
cleomiscosin A (18) and 5’-demethylaquillochin
(19) from M apelta has been reported by Cheng
et al [12]
Cembrane diterpenoids
Recently, several cembrane diterpenoids
10-hydroxycembren-5-one (20),
6-hydroxycembrene-5,10-dione (21) [9]
10,14-
Dihydroxy-5-isopropenyl-2,8,12-trimethyl-cyclotetradeca-2,8,12-trienone (22) [10,11] have
been isolated from M apleta
O O
O
CH2OH
H3CO
O
R2
R3
R1
17 OCH 3 OH OCH3
18 OCH 3 OH H
19 OCH 3 OH OH
R1 O
R2
20. OH,H H
22 OH,H OH
Figure 3: Cumarino-lignoids and cembrane diterpenoids isolated from M apelta
Trang 4Benzopyranoids
In 2001, An et al have isolated seven
benzopyran derivatives
4-hydroxy-2,6-dimethyl-
6-(3,7-dimethyl-2,6-octadienyl)-8-(3-methyl-2-butenyl)-2H-1-benzopyran-5,7(3H,6H)-dione
(23),
4-hydroxy-2,6,8-trimethyl-6-(3,7-
dimethyl-2,6-octadienyl)-2H-1-benzopyran-5,7(3H,6H)-dione (24),
5-hydroxy-2,8-
dimethyl-6-(3-methyl-2-butenyl)-8-(3,7-
dimethyl-2,6-octadiennyl)-2H-1-benzopyran-4,7(3H,8H)-dione (25),
5-hydroxy-2,8,6-
trimethyl-8-(3,7-dimethyl-2,6-octadiennyl)-2H-1-benzopyran-4,7-(3H,8H)-dione (26),
2,3-
dihydro-5,7-dihydroxy-2,6-dimethyl-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one (27),
2,3-dihydro-5,7-dihydroxy-2,8-dimethyl-6-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one (28),
and
2,3-dihydro-5,7-dihydroxy-2,6,8-trimethyl-4H-1-benzopyran-4-one (29) from the leaves of
M apelta [13]
O
OH
O
O
R1
CH3
R2
CH3
23 CH2-CH=C(CH3)-(CH2)2-CH=C(CH3)2 CH2-CH=C(CH3)2
24 CH2-CH=C(CH3)-(CH2)2-CH=C(CH3)2 CH3
O O
O
CH3
OH
R2
R1
25 CH2-CH=C(CH3)2 CH2-CH=C(CH3)-(CH2)2-CH=C(CH3)2
O
OH O
R1
O
CH3
CH3
R1
H3CO
OCH3
R2
O
R2
R1
Figure 4: Benzopyranoids isolated from M apelta
In recent years, a number of biologically
active secondary metabolites have been isolated
from M apelta which is widely distributed in
the northern areas of Vietnam From the
methanol extract of the M apelta, a new
chromene derivative with benzopyran skeleton
was isolated and identified as 1-(5,7-dimethoxy-2,2-dimethyl-2H-chromen-8-yl)-but-2-en-1-one
or malloapelta B (30) with high yield Different
chromatographic techniques were applied to
purify compounds
8-(1’-oxo-3’(R)-hydroxy-
Trang 5butyl)-5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran (31), 8-(acetic acid
1’-oxo-3’(R)-hydroxy-butyl
ester)-5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran (32);
6-(1’-oxo-2’-
en-butyl)-5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran (33),
6-[1'-oxo-3'(R)-hydroxy-
butyl]-5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran (34),
6-[1'-oxo-3'(R)-methoxy-
butyl]-5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran (35), and
6-(1’-oxo-2’,3’-epoxy-
butyl)-5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran (36) from the leaves of M apelta
which were named as malloapelta C, D, E, F, G,
and H, respectively [17, 18] These compounds
were evaluated their NF- B inhibitory, NFAT
transcription factor inhibitory and cytotoxic
activities (The cytotoxic assay was evaluated on
two cancer cell lines (Human hepatocellular
carcinoma, Hep-G2) and rhabdosarcoma, RD)
Interestingly, malloapelta B showed strong
NF-B inhibitory activity, NFAT transcription
factor inhibitory and cytotoxic activities, the
other compounds showed significant cytotoxic
activities against the two mentioned human
cancer cell lines [17, 18]
Miscellaneous compounds
Recently, the Chinese scientists carried out
an extensive screening for effective anti-HIV natural products Notably, the extract of the roots
of M apelta showed significant activity [8]
Based on the bioassay guided fractionation,
malloapeltine (37), 4-methoxy-3-cyano-pyridine 1-oxide (38), along with 4,5,4’-trimethyl-ellagic acid (39) were purified from the roots of this
plant [9] These compounds were evaluated for
their anti-HIV activity, among them 37
demonstrated a significant inhibitory activity [9] The following phytochemical examination of the
M apelta by Cheng et al led to the isolation of
two compounds named as 2 ,4
,15,16-tetrahy-droxydolabradan (40), malloapeltin (37) [10,11]
By repeated chromatography on silicagel column,
isopimpinellin (41), -tocopherol (42), trans-phytol (43), squalene (44) -carotene (45), lutein (46), and betulaprenol 10 (47) were isolated from
the methanol extract of this plant which were identified by comparison with the spectral data reported in the literatures [15, 16, 19]
N
OCH3
CN
O
N +
N O
O
-O
O
OH
H3CO
OCH3
H 3 CO
O
O
OH OH
OH HO
O
OCH 3 OCH3
41
OH
3
CH 2 OH
n n=9
O H
OH 2
2
44
45
46
O HO
42
Figure 5: Other compounds isolated from M apelta
Trang 6III - CHEMICAL MODIFICATIONS AND SYNTHESES
To investigate the relationship between the structure and their bioactivity as well as to find new derivatives having stronger effect, Binh et al synthesized the derivatives of malloapelta B by using electro organic synthetic method (see scheme 1) As a result, a new compound named as
bimalloapelta (48) and a known compound
8-[1’-oxo-3’(R)-methoxy-butyl]-5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran (49) were afforded (see scheme 2) [22, 23]
O
CH 3
H 3 C
H 3 C
O
O
CH 3
H 3 C
O
CH 3
H 3 C
O
CH 3
H 3 C
O
O
CH 3
H 3 C
+ClO 3
-+ClO 4- + 2e
e
-2
48
Scheme 1: Modifications of malloapelta B to produce 48 [22]
O
CH 3
H 3 C
H 3 C
O
O
CH 3
H 3 C
H 3 C
O
O
CH 3
H 3 C
H 3 C
O
H 3 CO
49
Scheme 2: Modifications of malloapelta B to produce 49 [23]
O
H3CO
OCH3
O
(C2H5)2NH
O
H3CO
OCH3
O CHOR3
(C2H5)2NH O
C H
H2 C
H3CO
OCH3
49 R=CH3 50 R=CH2CH3 51 R=CH2CH2CH3 52 R=CH(CH3)2
Scheme 3: Modifications of malloapelta B to produce 49 - 52 [25]
O
H3CO
OCH3
O
HNO3/H2SO4 CHCl3
O
H3CO
OCH3
O
NO2
53
Scheme 4: Modification of malloapelta B to produce 53 [25]
Trang 7As part of our ongoing studies to look for new derivatives having stronger bioactivities, nine
benzopyrans 8-[1’-oxo-3’(R)-methoxy-butyl]-5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran (49), ethoxy-butyl]-5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran (50), 8-[1’-oxo-3’(R)-propoxy-butyl]-5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran (51),
8-[1’-oxo-3’(R)-isopropoxy-butyl]-5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran (52),
8-[1’-oxo-2’-en-butyl]-5,7-dimethoxy-3-nitro-2,2-dimethyl-2H-1-benzopyran (53), 8-[1’-oxo-3’(R)-methyl-4’-acetyl-5’-oxo-hexyl]-5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran (54), (methylformiate)-5’-oxo-hexyl)-5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran (55),
8-(1’-oxo-3’(R)-methyl-4’(S/R)-(ethylformiate)-5’-oxo-hexyl)-5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran (56), and 1-(5,7-dimethoxy-2,2-dimethyl-2H-chromen-8-yl)butan-1-one (57) were synthesized by addition, nitration
and Michael reactions from malloapleta B [24, 25, 26]
O
H3CO
OCH 3
O
CH3COCH2R Michael reaction
OCH 3
CH 3
O
O
CH3
CH3 O
O
O
H 3 CO
OCH 3
O
R
H 3 C
OCH 2 CH 3
CH3 O
O
55 R=
Scheme 5: Modifications of malloapelta B to produce 54 - 56 [24]
O C H 3
CH 3
O CH 3
H 3 C O O
C O O C H 3
CO O C H 3
O C H 3
C H 3
O C H 3
H 3 C O O
O
C H 3
C H 3
C H 3
O C H3
H 3 C O
O
C H 3
C H 3
C H 3
O C H 3
H 3 C O
H O
O
C H 3
C H 3
C H 3
O C H 3
H 3 C O O O
C H 3
C H 3
C H 3
O C H 3
H 3 C O
O
O
C H 3
C H 3
C H 3
O C H 3
H 3 C O
H 3 C O O
C H 3
C H 3
C H 3
O C H 3
H 3 C O
O
H2/Pd-C
30 psi
H2/Pd-C
15 psi
D im ethyl m alonate
N aO C H3
1) C H3C H2M gB r 2) N H4C l/H2O
1) L iA lH 4
2) H 2 O /M eO H
N aB H4/M eO H 10-15 0 C
57 58 59
62 63
Scheme 6: Modifications of malloapelta B to produce 57 - 63 [26]
Trang 8The other method for synthesizing of malloapelta B’s derivatives has been reported by Chinh
et al [26] Compounds 1-(5,7-dimethoxy-2,2-dimethyl-2H-chromen-8-yl)butan-1-one (57) was
produced by reducing malloapelta B in sodium borohydride environment (see scheme 6),
1-(5,7-dimethoxy-2,2-dimethylchroman-8-yl)butan-1-one (58), 8-butyl-5,7-dimethoxy-2,2-dimethylchroman (59) were produced by reducing malloapleta B in catalytic hydrogenation (see
Scheme 6) The other compounds
dimethoxy-2,2-dimethyl-2H-chromen-8-yl)-3-methoxy-1-butene (60), dimethoxy-2,2-dimethyl-2H-chromen-8-yl)-3-hydroxy-1-dimethoxy-2,2-dimethyl-2H-chromen-8-yl)-3-methoxy-1-butene (61), 1-(5,7-dimethoxy-2,2-dimethyl-2H-chromen-8-yl)-3-methylpentan-1-one (62), and
2-(4-(5,7-dimethoxy-2,2-dimethyl-2H-chromen-8-yl)-4-oxobutan-2-yl)malonate (63) were synthesized from malloapelta
B by addition reaction (see Scheme 6) By applying this method we also obtained the same
compounds The summary of synthesized compounds from malloapelta B by these methods is
exhibited in Figure 6
CH3
O
OR
CH3
H3CO
49. CH3
50 CH2CH3
51 CH2CH2CH3
52 CH(CH3)2
CH3
O
R
CH3
H3CO
OCH3
CH3
CH3 O O
CH3 O O
OCH2CH3
CH3 O O
O
CH3
H3C
CH3
H3C
CH3
H3C
O O
OCH3H3CO
H
48
O
H3CO
OCH3
O
NO2
O O
H3CO
OCH3
O O
H3CO
OCH3
O
H3CO
OCH3
59
O
H3CO
OCH3
O CH3
O
H3CO
OCH3
OH
O O
H3CO
OCH3
O
O
-O O
OCH 3
H 3 CO
Figure 6: Synthesized compounds from malloapelta B
Trang 9IV - STRUCTURES AND BIOLOGICAL
ACTIVITIES OF SYNTHESIZED
COMPOUNDS
It is well-known that LPS or TNF induced
NF-.B activation are related to septic shock,
autoimmune disorders, and inflammatory
diseases [27,28] It is also agreed that
compounds containing , -unsaturated carbonyl
moiety usually exhibit good inhibitory activity
against these factors [26, 27] Interestingly,
benzopyrans, with , -unsaturated carbonyl
group, also display this characteristic [20, 21]
Malloapleta B with , -unsaturated
carbonyl motiety in side chain presented a
potent NF-.B inhibitory activity (IC50 = 5.0
µM), and NFAT transcription factor inhibitory
(IC50 = 2.48 µM) and cytotoxic activity against
two human cancer cell lines (Hep-G2 and KB
with IC50 = 0.49 µg/ml and 0.54 µg/ml,
respectively) [20, 21] Therefore, malloapelta B
were selected for studying the relationship
between structure and biological activity In the
structure of malloapelta B (see Figure 7) we
proposed three positions A, B, C which seem to
be active in organic reaction To investigate the
relationship between structure and biological
activity of this compound, we modified its
structure by changing individual A, B, C
position or both A and B, A and C, B and C to
produce some derivatives Then the biological
activity of the derivatives were retested by the
same method applied for malloapelta B [18, 20,
21, 25] The relationship studies between
structure and biological activity of the
derivatives and malloapleta B were carried out
by comparing their biological activity with that
of malloapelta B
Binh et al [22] modified the structure of
malloapelta B by using cyclic voltammetry to
oxidize the C position, in this method, a
mechanism of electro organic oxidation of
malloapelta B was proposed as shown in scheme
1 Firstly, malloapelta B transferred one electron
to convert into corresponding cation radical,
which was further oxidized by LiClO4 then
converted into 48 This compound was tested on
Hep-G2 and RD cells As a result, 48 exhibited
strongly cytotoxic activity on both tested cell lines with the IC50 values of 0.46 µg/ml and 0.33
µg/ml, respectively
O
H 3 CO
OCH 3
O
2
3 4 5
6 7
8 9 10
11
12
1' 2' 3' 4'
Figure 7: Three positions A, B, C in the
structure of malloapelta B Comparing these results with those of
malloapelta B, the IC50 values of both compounds were similar and that the oxidation
of double bond at C-3/C4 (C position) did not affect to their cytotoxic activity The other method [25] to modify the C position (double
bond at C-3/C4) of the structure of malloapelta
B was applied by using nitration reaction (see
scheme 3) to produce 53 In this method the
hydrogen atom (H-3) of the C position on structure of malloapleta B was replaced by the
NO2 group This compound also exhibited strongly cytotoxic activity on both tested cell lines Hep-G2 and RD with the IC50 values of 0.87 µg/ml and 0.62 µg/ml, respectively
Comparing these resutls with those of
malloapelta B, the IC50 values of this compound was slightly higher The observed result suggested that the addition of NO2 group into
the position C in the structure of malloapelta B
was not affect the cytotoxic activities The decreasing cytotoxic activity of this compound due to NO2group obstructed the access into the
C position of structure of malloapelta B [25] The B position on the structure of malloapelta B
was also modified by an electro organic
oxidation method to produce compound 49 (see scheme 2) [23] The B position was made partial changes by an addition reaction and Michael
reaction with different reagents to produce
C
Trang 10compounds 49-52, 54-57, 62-63 (see scheme
3,5,6) [24,25,26] The reduction of double bond
(B position) and carbonyl group (A position)
was attempted by catalytic hydrogenation of
malloapelta B at 30 psi of H2gas in the presence
of 10% Pd/C resulted in the conversion of ,
-unsaturated carbonyl to butyl yielded compound
59 (see scheme 6) However, by carrying out the
same reaction at 15 psi of H2gas in the presence
of 10% Pd/C, this reaction reduced the double
bond (B position) and saturation of 3,4 double
bond (C position) in the pyran ring to yield
compound 58 (see scheme 6) Compound 60
and 61 were produced by treating malloapelta B
with lithium aluminum hydride The results are
much complicated with the formation of
isomerizied products 60 and 61 as showed in the
scheme 6 [26] Those compounds above were
assayed for their inhibitory activity on
TNF-induced, NF-.B using transfected Hela cell and
the results are described in the literature [26]
The authors concluded that only 59 showed the
slightly decreased inhibitory activity The rest of
compounds showed the NF- B inhibitory
activity at nearly the same concentration of cell
cytotoxicity Thus these compounds are
considered to be inactive The results revealed
that , -unsaturated carbonyl moiety and the
C=C double bond plays an important role to the
activity of malloapelta B According to the
discussion above, mallotapelta B still showed
the most interesting biological activities
V - CONCLUDING REMARKS
Numerous compounds have been isolated
and identified from Mallotus apelta since the
last two decades They were classified under the
categories triterpenoids, steroids, flavonoids,
cumarino-lignoids, cembrane diterpenoids,
benzopyranoids and miscellaneous compounds
Among them, benzopyranoids were known to be
the most identified components from this plant
Interestingly, the results of biological activity
assay showed that malloapelta B, a major
component of M apelta, exhibited considerable
NF- B and NFAT transcription factor inhibitory
and cytotoxic activities Consequently, great
efforts have been made to modify the structure
of malloapelta B for pharmaceutical tests As a result, sixteen derivatives were obtained Structure-activity relationship studies on the synthesized compounds revealed that , -unsaturated carbonyl moiety and the C=C double bond plays an important role to the activity of malloapelta B It is clear that for a number of studies on the synthesis of some new derivatives, malloapelta B presented the most interesting biological activities
REFERENCES
1 N N Thin The appendix of Vietnamese plant species, Agriculture Publishing House, Hanoi, Vol II, P 626 - 633 (2003)
2 D T Loi Glossary of Vietnamese Medicinal Plants, Publishing House Science and Technology, Hanoi (2001)
3 V V Chi Vietnamese Medical Plant Dictionary, Science & Technology Publishing House, Hanoi (2001)
4 R Bauer Drug Inform J, Vol 32, P 101 -
110 (1998)
5 V E Tyler J Nat Prod., Vol 62, P 1589 -
1592 (1999)
6 G B Mahady, H H S Fong, N R Farnsworth The Netherlands (2001)
7 X Q Shan, and L B Feng Zhi Wu Xue Bao, Vol 27, No 2, P 192 (1985)
8 Katsuhiko, N Hideo, and Z M Meng Chem Pharm Bull., Vol 37, No 7, P 1810 (1989)
9 Katsuhiko, N Hideo, and Z M Meng Chem Pharm Bull., Vol 37, No 7, P 1810 (1989)
10 X F Cheng, Z M Meng, Z L Chen Phytochemistry, Vol 49, No 7, P 2193 -
2194 (1998)
11 X F Cheng, Z L Chen, Z M Meng Journal of Asian Natural Product Research, Vol 1, No 3, P 163 - 168 (1999)
12 X F Cheng , Z L Chen Journal of Asian Nat Prod Research, Vol.1, No 4, P 319 -
25 (1999)
13 X F Cheng, Z L Chen Fitoterapia, Vol